Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Meixi Peng"'
Autor:
Huanhuan Qin, Meixi Peng, Jingsong Cheng, Zhenyu Wang, Yinghui Cui, Yongxiu Huang, Yaoqi Gui, Yanni Sun, Wenqiong Xiang, Xiaomei Huang, Ting Huang, Li Wang, Jieping Chen, Yu Hou
Publikováno v:
Cell Death and Disease, Vol 15, Iss 7, Pp 1-14 (2024)
Abstract Leukemia stem cells (LSCs) are recognized as the root cause of leukemia initiation, relapse, and drug resistance. Lipid species are highly abundant and essential component of human cells, which often changed in tumor microenvironment. LSCs r
Externí odkaz:
https://doaj.org/article/99fc0f004bf8438dbfa73af3155ea628
Autor:
Jun Ren, Yonghong Tao, Meixi Peng, Qiaoling Xiao, Yipei Jing, Junpeng Huang, Jing Yang, Can Lin, Minghui Sun, Li Lei, Zesong Yang, Zailin Yang, Ling Zhang
Publikováno v:
Cell Death and Disease, Vol 13, Iss 10, Pp 1-15 (2022)
Abstract Acute myeloid leukemia (AML) is a rapidly progressing and often fatal hematopoietic malignancy. Venetoclax (VEN), a recent FDA-approved BCL-2 selective inhibitor, has high initial response rates in elderly AML patients, but the majority of p
Externí odkaz:
https://doaj.org/article/67e5806f623b499088034fcebf348668
Autor:
Meixi Peng, Dan Yang, Yixuan Hou, Shuiqing Liu, Maojia Zhao, Yilu Qin, Rui Chen, Yong Teng, Manran Liu
Publikováno v:
Cell Death and Disease, Vol 14, Iss 9, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/2b15f4005dbe428d8b1b552d20ebaea1
Autor:
Yipei Jing, Xueke Jiang, Li Lei, Meixi Peng, Jun Ren, Qiaoling Xiao, Yao Tao, Yonghong Tao, Junpeng Huang, Lu Wang, Yuting Tang, Zailin Yang, Zesong Yang, Ling Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-23 (2021)
Abstract Background Acute myeloid leukemia (AML) with mutated nucleophosmin (NPM1), which displays a distinct long noncoding RNA (lncRNA) expression profile, has been defined as a unique subgroup in the new classification of myeloid neoplasms. Howeve
Externí odkaz:
https://doaj.org/article/9adc295464fd44b395e9df2ba3712621
Autor:
Qiaoling Xiao, Can Lin, Meixi Peng, Jun Ren, Yipei Jing, Li Lei, Yonghong Tao, Junpeng Huang, Jing Yang, Minghui Sun, Jing Wu, Zailin Yang, Zesong Yang, Ling Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Exosomal long non-coding RNAs (lncRNAs) have emerged as a cell-free biomarker for clinical evaluation of cancers. However, the potential clinical applications of exosomal lncRNAs in acute myeloid leukemia (AML) remain unclear. Herein, we attempted to
Externí odkaz:
https://doaj.org/article/a1b6c4766d3e46f38fb53e32847a3a2b
Autor:
Yilu Qin, Yixuan Hou, Shuiqing Liu, Pengpeng Zhu, Xueying Wan, Maojia Zhao, Meixi Peng, Huan Zeng, Qiao Li, Ting Jin, Xiaojiang Cui, Manran Liu
Publikováno v:
Advanced Science, Vol 9, Iss 24, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/f74b7a5906944f6ab889efc48a3bff93
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by multiple cytogenetic and molecular abnormalities, with a very poor prognosis. Current treatments for AML often fail to eliminate leukemic stem cells (LSCs), which
Externí odkaz:
https://doaj.org/article/36de23b7b3b5468eaf5887098a1d46a9
Autor:
Qiaoling Xiao, Li Lei, Jun Ren, Meixi Peng, Yipei Jing, Xueke Jiang, Junpeng Huang, Yonghong Tao, Can Lin, Jing Yang, Minghui Sun, Lisha Tang, Xingyu Wei, Zailin Yang, Ling Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Acute myeloid leukemia (AML) with nucleophosmin 1 (NPM1) mutations exhibits distinct biological and clinical features, accounting for approximately one-third of AML. Recently, the N6-methyladenosine (m6A) RNA modification has emerged as a new epigene
Externí odkaz:
https://doaj.org/article/1e59047ba36441a1bb95a3ce368cc176
Autor:
Junpeng Huang, Minghui Sun, Yonghong Tao, Jun Ren, Meixi Peng, Yipei Jing, Qiaoling Xiao, Jing Yang, Can Lin, Li Lei, Zailin Yang, Ling Zhang
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 1624 (2023)
Acute myeloid leukemia (AML) with a nucleophosmin 1 (NPM1) mutation is a unique subtype of adult leukemia. Recent studies show that NPM1-mutated AML has high autophagy activity. However, the mechanism for upholding the high autophagic level is still
Externí odkaz:
https://doaj.org/article/9846782ffd6a4a2eb832cccc69607871
Autor:
Meixi Peng, Jun Ren, Yipei Jing, Xueke Jiang, Qiaoling Xiao, Junpeng Huang, Yonghong Tao, Li Lei, Xin Wang, Zailin Yang, Zesong Yang, Qian Zhan, Can Lin, Guoxiang Jin, Xian Zhang, Ling Zhang
Publikováno v:
Journal of Extracellular Vesicles, Vol 10, Iss 13, Pp n/a-n/a (2021)
Abstract Acute myeloid leukaemia (AML) carrying nucleophosmin (NPM1) mutations has been defined as a distinct entity of acute leukaemia. Despite remarkable improvements in diagnosis and treatment, the long‐term outcomes for this entity remain unsat
Externí odkaz:
https://doaj.org/article/cb84c96563384f6794e5ae30574aab8d